New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
10:46 EDTCPIXCumberland falls after Wells Fargo analyst cuts rating
Drug maker Cumberland Pharmaceuticals (CPIX) is falling after Wells Fargo analyst Michael Tong downgraded the stock to Market Perform from Outperform in a note to investors earlier this morning. Another pharmaceutical company, Innopharma, has received FDA approval to market a generic version of Cumberland's Acetadopte, a treatment for chronic pulmonary disease and acute bronchopulmonary disease, the analyst wrote. Tong doesn't know when Innopharma will begin marketing its drug, and he believes that Cumberland may seek a preliminary injunction that could postpone the launch. Still, the analyst believes that Cumebrland's stock is unlikely to appreciate as long as uncertainty about the matter persists. In mid-morning trading, Cumberland fell 27c, or 4.88%, to $5.22.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 25, 2016
08:05 EDTCPIXCumberland and Piramal launch co-promotion of Caldolor and Vaprisol
Piramal Critical Care, an integral business unit of Piramal Enterprises and Cumberland Pharmaceuticals announced that they have officially launched co-promotion of two of Cumberland's branded hospital products, Caldolor and Vaprisol throughout the U.S. Caldolor, ibuprofen, Injection is the first injectable product approved in this country for the treatment of pain and fever in adults. The brand recently received FDA approval for the management of pain and reduction of fever use in pediatric patients six months and older. Vaprisol is the only injectable brand available to treat hyponatremia, the most common electrolyte imbalance in U.S. hospitalized patients.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use